Compounds with biological roles [BR:br08001]
Steroids
24-Carbon atoms
Cholane derivatives
C00695 Cholic acid
Lipids [BR:br08002]
ST Sterol lipids
ST04 Bile acids and derivatives
ST0401 C24 bile acids, alcohols, and derivatives
C00695 3alpha,7alpha,12alpha-Trihydroxy-5beta-cholanic acid
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A05 BILE AND LIVER THERAPY
A05A BILE THERAPY
A05AA Bile acid and derivatives
A05AA03 Cholic acid
D10699 Cholic acid (JAN/USAN) <US>
USP drug classification [BR:br08302]
Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
Cholic Acid
D10699 Cholic acid (JAN/USAN)
Risk category of Japanese OTC drugs [BR:br08312]
Third-class OTC drugs
Inorganic and organic chemicals
Cholic acid
C00695 Cholic acid
Drug groups [BR:br08330]
Gastrointestinal agent
DG01956 Bile acid preparation
D10699 Cholic acid
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Liver X receptor like receptor
NR1H4 (FXR)
D10699 Cholic acid (JAN/USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D10699
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D10699
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10699
Compounds with biological roles [BR:br08001]
Steroids
24-Carbon atoms
Cholane derivatives
C02528 Chenodeoxycholate
Lipids [BR:br08002]
ST Sterol lipids
ST04 Bile acids and derivatives
ST0401 C24 bile acids, alcohols, and derivatives
C02528 3alpha,7alpha-Dihydroxy-5beta-cholanic acid
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A05 BILE AND LIVER THERAPY
A05A BILE THERAPY
A05AA Bile acid and derivatives
A05AA01 Chenodeoxycholic acid
D00163 Chenodiol (USAN) <JP/US>
USP drug classification [BR:br08302]
Gastrointestinal Agents
Gastrointestinal Agents, Other
Chenodiol
D00163 Chenodiol (USAN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
23 Digestive organ agents
236 Cholagogues
2362 Bile acids
D00163 Chenodiol (USAN); Chenodeoxycholic acid (JP18/INN)
Drug groups [BR:br08330]
Gastrointestinal agent
DG01956 Bile acid preparation
D00163 Chenodiol
Target-based classification of drugs [BR:br08310]
Nuclear receptors
Thyroid hormone like receptors
Liver X receptor like receptor
NR1H4 (FXR)
D00163 Chenodiol (USAN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00163 Chenodeoxycholic acid
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D00163
Lipids [BR:br08002]
ST Sterol lipids
ST04 Bile acids and derivatives
ST0402 C26 bile acids, alcohols, and derivatives
C05466 Glycochenodeoxycholic acid
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R06 ANTIHISTAMINES FOR SYSTEMIC USE
R06A ANTIHISTAMINES FOR SYSTEMIC USE
R06AX Other antihistamines for systemic use
R06AX26 Fexofenadine
D07958 Fexofenadine (INN)
Risk category of Japanese OTC drugs [BR:br08312]
First-class OTC drugs
Inorganic and organic chemicals
Fexofenadine
D07958 Fexofenadine (INN)
Second-class OTC drugs
Inorganic and organic chemicals
Fexofenadine
D07958 Fexofenadine (INN)
Drug groups [BR:br08330]
Anti-allergic agent
DG01557 Histamine receptor antagonist
DG01482 Histamine receptor H1 antagonist
DG01117 Fexofenadine
D07958 Fexofenadine
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Histamine
HRH1
D07958 Fexofenadine (INN)
6 Ala is modified by N-methyldehydro. (i.e. N-Methyldehydroalanine, Mdha)
9 D-Asp is modified by erythro-beta-methyl. (i.e. D-erythro-beta-Methylaspartic acid, D-MeAsp)
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J02 ANTIMYCOTICS FOR SYSTEMIC USE
J02A ANTIMYCOTICS FOR SYSTEMIC USE
J02AX Other antimycotics for systemic use
J02AX04 Caspofungin
D07626 Caspofungin (INN)
Antimicrobials [BR:br08307]
Antifungals
Cell membrane function inhibitor
Echinocandin
D07626 Caspofungin (INN)
Antimicrobials abbreviations [BR:br08327]
Antifungals
Cell membrane function inhibitor
Echinocandin
DG00636 Caspofungin
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
C CARDIOVASCULAR SYSTEM
C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09C ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), PLAIN
C09CA Angiotensin II receptor blockers, plain
C09CA03 Valsartan
D00400 Valsartan (JP18/USP/INN) <JP/US>
USP drug classification [BR:br08302]
Cardiovascular Agents
Angiotensin II Receptor Antagonists
Valsartan
D00400 Valsartan (JP18/USP/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
214 Antihypertensives
2149 Others
D00400 Valsartan (JP18/USP/INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01925 Renin-angiotensin system inhibitor
DG01495 Angiotensin II receptor antagonist
D00400 Valsartan
Metabolizing enzyme substrate
DG01642 CYP2C9 substrate
D00400 Valsartan
Transporter substrate
DG02861 ABCC2 substrate
D00400 Valsartan
DG02856 SLCO1B1 substrate
D00400 Valsartan
DG02932 SLCO1B3 substrate
D00400 Valsartan
Drug classes [BR:br08332]
Cardiovascular agent
DG01925 Renin-angiotensin system inhibitor
D00400 Valsartan
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Angiotensin
AGTR1
D00400 Valsartan (JP18/USP/INN) <JP/US>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D00400 Valsartan
D00400 Valsartan tablets
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D00400
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D00400
Drug transporters
D00400
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01C PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
L01CD Taxanes
L01CD02 Docetaxel
D07866 Docetaxel (JAN/INN) <JP/US>
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
424 Plant extract preparations
4240 Plant extract preparations
D07866 Docetaxel (JAN/INN)
Drug groups [BR:br08330]
Metabolizing enzyme substrate
DG01633 CYP3A/CYP3A4 substrate
DG02913 CYP3A4 substrate
DG00694 Docetaxel
D07866 Docetaxel
Target-based classification of drugs [BR:br08310]
Not elsewhere classified
Cellular process
Cytoskeleton
TUBB
D07866 Docetaxel (JAN/INN) <JP/US>
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D07866
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D07866